Atlas Trials

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Clinical trial NCT00568633 · TERMINATED

Trial details

NCT number
NCT00568633
Sponsor
Stanford University
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Leukemia, MyeloidLeukemiaAcute Myeloid Leukemia (AML)
Start date
2007-08-01
Primary completion
2015-12-31
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.